Terms: = Lung cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Clinical Outcome
4 results:
1. Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.
Chebib N; Archer F; Bobet-Erny A; Leroux C; Cottin V
Sci Rep; 2018 Oct; 8(1):14698. PubMed ID: 30279475
[TBL] [Abstract] [Full Text] [Related]
2. A Model of Lymphangioleiomyomatosis in a Three-Dimensional Culture System.
Kumasaka T; Hoshika Y; Kobayashi E; Mitani K; Okura MK; Hong YK; Takahashi K; Seyama K
Lymphat Res Biol; 2015 Dec; 13(4):248-52. PubMed ID: 26574997
[TBL] [Abstract] [Full Text] [Related]
3. Favorable response to antigonadal therapy for a benign metastasizing leiomyoma.
Taveira-DaSilva AM; Alford CE; Levens ED; Kotz HL; Moss J
Obstet Gynecol; 2012 Feb; 119(2 Pt 2):438-442. PubMed ID: 22270431
[TBL] [Abstract] [Full Text] [Related]
4. tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
[TBL] [Abstract] [Full Text] [Related]
